Paclitaxel (Taxol): An Inhibitor of Angiogenesis in a Highly Vascularized Transgenic Breast Cancer-Reference-Cited by-同舟云学术

Paclitaxel (Taxol): An Inhibitor of Angiogenesis in a Highly Vascularized Transgenic Breast Cancer

Published:1999-02 Issue:1 Volume:14 Page:31-36
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Lau Derick H.,Xue Ling,Young Lawrence J.,Burke Patricia A.,Cheung Anthony T.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.1999.14.31

Reference13 articles.

1. Promotion of microtubule assembly in vitro by taxol

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Slow Sulfide Donor GYY4137 Increased the Sensitivity of Two Breast Cancer Cell Lines to Paclitaxel by Different Mechanisms;Biomolecules;2024-05-31

2. Upfront Taxane Could Be Superior to Pegylated Liposomal Doxorubicin (PLD): A Retrospective Real-World Analysis of Treatment Sequence Taxane–PLD versus PLD–Taxane in Patients with Metastatic Breast Cancer;Cancers;2023-10-12

3. Bioactive compounds and biomedical applications of endophytic fungi: a recent review;Microbial Cell Factories;2023-06-06

4. Lactobacillus rhamnosusGG alleviates colitis caused by chemotherapy via biofilm formation;Journal of Gastroenterology and Hepatology;2023-03-23

5. Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis;Aging;2022-02-26